Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Premature Ovarian Insufficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Shanghai Changhai Hospital, Shanghai, China